Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Legend Biotech Corporation (NASDAQ: LEGN)
LEGN Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
24%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
79.70%
LEGN Stock Analysis
LEGN
PE Ratio:
LEGN
PEG Ratio:
LEGN
Forward EPS Growth (12 month):
349.20%
LEGN
PS Ratio:
5.8
LEGN
PSG Ratio:
0.2
LEGN
Forward Revenue Growth (12 month):
30.10%
LEGN Articles
No data was found